ATHA - Athira Pharma, Inc.

Oversold Signal for 06-24-2022
Oversold Stock Signal: ATHA

Stock Signal Information


Oversold Stock
Report Date: 06-24-2022
Symbol: ATHA - Athira Pharma, Inc.
Oversold Stock Signal: ATHA

ATHA Technical Chart

Company Contact

Athira Pharma, Inc. (ATHA)
4000 Mason Road
Seattle, WA 98011-2141
Phone: 206-221-8112
Website: http://www.athira.com
CEO: Dr. Leen Kawas

Company Profile

Athira Pharma, Inc., a clinical-stage biopharmaceutical company, develops small molecules to restore neuronal health and stop neurodegradation. Its lead product candidate is ATH-1017, a blood brain barrier-penetrating, small hepatocyte growth factor/MET activator that is in various clinical trials for the treatment of Alzheimer's and Parkinson's diseases. The company also develops product candidates, which are in preclinical stage, including ATH-1019 for depression; and ATH-1018 for peripheral neuropathy. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is based in Seattle, Washington.

Top Stock Signals

free trading signals, best trading signals, options trade signals

About Top Stock Signals

Good stock signals have been found on this server. That is all we know.

Phone: +1 (407) 559-7228
Email: [email protected]

About Us | Newsletter | Members

Most Active
Top Gainers
Top Losers